Idiopathic Interstitial Pneumonias
Showing 1 - 25 of 3,485
Idiopathic Interstitial Pneumonias: a Prospective Study
Recruiting
- Idiopathic Interstitial Pneumonia
- +2 more
- Microarray analysis
-
London, Ontario, CanadaLondon Health Science Centre
Oct 15, 2021
Interstitial Lung Disease, Idiopathic Interstitial Pneumonias, Drug-Induced Pneumonitis Trial in Los Angeles (68Ga-FAPi-46,
Recruiting
- Interstitial Lung Disease
- +6 more
- 68Ga-FAPi-46
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
May 6, 2022
Hormone Sensitivity and Imaging of Idiopathic Interstitial
Completed
- Idiopathic Interstitial Pneumonia
- high resolution CT
-
Beijing, Beijing, ChinaPeking University Third Hospital
Nov 23, 2021
Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Sarcoidosis Trial in Charlottesville (Interstitial Lung Disease)
Enrolling by invitation
- Interstitial Lung Disease
- +5 more
- Interstitial Lung Disease
-
Charlottesville, VirginiaUniversity of Virginia Health System
May 20, 2021
Idiopathic Pulmonary Fibrosis, Idiopathic Interstitial Pneumonia, Interstitial Lung Diseases Trial in Worldwide (patient
Recruiting
- Idiopathic Pulmonary Fibrosis
- +3 more
- patient registry (observation and biomaterial sampling)
-
Vienna, Austria
- +6 more
Nov 2, 2021
Microorganism of Cryptogenic Mechanical Pneumonia Through Next
Recruiting
- Cryptogenic Organizing Pneumonia
- Idiopathic Interstitial Pneumonias
- Next-generation sequencing
-
Shanghai, Please Select, China
- +1 more
Aug 30, 2020
Pulmonary Arterial Hypertension, Pulmonary Hypertension, Interstitial Lung Disease Trial in Germany, United States (Bardoxolone
Completed
- Pulmonary Arterial Hypertension
- +11 more
- Bardoxolone methyl
- Placebo
-
Phoenix, Arizona
- +31 more
Nov 12, 2021
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)
Recruiting
- Idiopathic Pulmonary Fibrosis
- +3 more
-
Aurora, Colorado
- +3 more
Sep 11, 2020
Idiopathic Interstitial Pneumonia Trial in Japan
Active, not recruiting
- Idiopathic Interstitial Pneumonia
-
Kiyosu, Aichi, Japan
- +85 more
Mar 16, 2021
Idiopathic Pulmonary Fibrosis, Fibrosis, Idiopathic Interstitial Pneumonias Trial in Worldwide (CC-90001, Placebo)
Completed
- Idiopathic Pulmonary Fibrosis
- +6 more
- CC-90001
- Placebo
-
Loma Linda, California
- +94 more
Feb 4, 2022
stratification for IPF and COPD
Not yet recruiting
- Lung; Disease, Interstitial, With Fibrosis
- +2 more
- Lung auscultation
- +3 more
-
Sion, Wallis, SwitzerlandCentre Hospitalier du Valais Romand
Sep 1, 2022
Progressive Fibrosing Interstitial Lung Disease
Completed
- Lung Diseases, Interstitial
-
Ridgefield, ConnecticutBoehringer Ingelheim Pharmaceuticals, Inc.
May 16, 2023
Idiopathic Pulmonary Fibrosis, Systemic Sclerosis With Lung Involvement Trial in El Paso (Vixarelimab, Placebo)
Recruiting
- Idiopathic Pulmonary Fibrosis
- Systemic Sclerosis With Lung Involvement
- Vixarelimab
- Placebo
-
El Paso, TexasEl Paso Pulmonary Association Elligo PPDS
Mar 14, 2023
Evaluation of Connective Tissue Disease Incidence During
Unknown status
- Idiopathic Interstitial Pneumonia
- Follow-up
-
Lille, France
- +1 more
Nov 25, 2019
Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Interstitial Pneumonitis Trial in Bethesda, Falls Church (Aerobic
Recruiting
- Interstitial Lung Disease
- +3 more
- Aerobic Exercise Training (AET)
- No AET (education only)
-
Bethesda, Maryland
- +1 more
Jan 18, 2023
Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis Trial (Hyperoxia)
Not yet recruiting
- Interstitial Lung Disease
- +4 more
- Hyperoxia
- (no location specified)
Nov 1, 2022
Interstitial Lung Disease, Sarcoidosis, Idiopathic Pulmonary Fibrosis Trial in Kansas City
Recruiting
- Interstitial Lung Disease
- +4 more
-
Kansas City, KansasThe University of Kansas Medical Center
Nov 5, 2022
Families-At-risk for Interstitial Lung Disease Study
Active, not recruiting
- Interstitial Lung Disease
- Idiopathic Pulmonary Fibrosis
-
New York, New YorkColumbia University Irving Medical Center
Jul 19, 2022
Mechanisms of Familial Pulmonary Fibrosis
Recruiting
- Familial Pulmonary Fibrosis
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Mar 29, 2022
Idiopathic Pulmonary Fibrosis Registry for Future Studies
Completed
- Lung Disease, Interstitial
- Idiopathic Pulmonary Fibrosis
-
Columbus, OhioThe Ohio State University
Nov 1, 2021
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Trial in Kissimmee, Kansas City, Chesterfield (Inhaled Treprostinil,
Enrolling by invitation
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Inhaled Treprostinil
- Treprostinil Ultrasonic Nebulizer
-
Kissimmee, Florida
- +2 more
Jul 19, 2022
Interstitial Lung Diseases Trial in Wenzhou (Anlotinib, Placebo)
Recruiting
- Interstitial Lung Diseases
- Anlotinib
- Placebo
-
Wenzhou, Zhejiang, ChinaThe First Affiliated Hospital of Wenzhou Medical University
Apr 13, 2023
Pulmonary Fibrosis, Interstitial Lung Disease, Lung Fibrosis Trial in Chicago
Recruiting
- Pulmonary Fibrosis
- +3 more
-
Chicago, IllinoisPulmonary Fibrosis Foundation
Oct 28, 2022
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Trial (Placebo, Inhaled Treprostinil, Treprostinil Ultrasonic
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Placebo
- +2 more
- (no location specified)
Feb 15, 2022
Safety of Nintedanib in Real World in China
Not yet recruiting
- Pulmonary Fibrosis
-
Beijing, ChinaChina-Japan Friendship Hospital
Jan 26, 2023